Nasdaq

forest

Biotech

Treeline sees path to public markets via reverse merger

The deal is expected to close in the second half of this year and should leave Treeline with $900 million in cash, enough to last into 2029.

Darren Incorvaia Jun 8, 2026 10:37am

Medtronic MiniMed 780G

Newly minted MiniMed nets CE mark for 780G pump, Instinct CGM

Mar 11, 2026 10:05am

Wall Street IPO

Behind Generate's 'feverish' race to raise $400M IPO

Feb 27, 2026 3:36am

IPO initial public offering Wall Street

Generate plans $425M IPO to bankroll phase 3 asthma trials

Feb 23, 2026 9:42am

IPO initial public offering

Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M

Feb 6, 2026 4:04am

IPO initial public offering Wall Street

Eikon upsized $381M listing marks largest biotech IPO since 2024

Feb 5, 2026 4:23am